S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Halle C Moore, MD
The Cleveland Clinic
Principal Investigator - Kathy S. Albain, MD
Loyola University
Study Chair - Kelly-Anne Phillips
Peter MacCallum Cancer Centre, Australia
Study Chair - Lori J. Goldstein, MD
Fox Chase Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mater Hospital - North Sydney
North Sydney, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Newcastle Mater Misericordiae Hospital
Waratah, New South Wales, Australia
- Royal Adelaide Hospital Cancer Centre
Adelaide, South Australia, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Ballarat Oncology and Haematology Services
Ballarat, Victoria, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- Monash Medical Center - Clayton Campus
Clayton, Victoria, Australia
- Peter Maccallum Cancer Centre
East Melbourne, Victoria, Australia
- Maroondah Hospital
East Ringwood, Victoria, Australia
- St. Vincent'S Hospital - Melbourne
Fitzroy, Victoria, Australia
- Royal Melbourne Hospital
Parkville, Victoria, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- Centre Hospitalier Hutois
Huy, Belgium
- U.Z. Gasthuisberg
Leuven, Belgium
- Chu Liege - Domaine Universitaire Du Sart Tilman
Liège, Belgium
- Centre Hospitalier Regional de la Citadelle
Liège, Belgium
- Az Damiaan
Ostend, Belgium
- Centre Hospitalier Peltzer-la Tourelle
Verviers, Belgium
- National Institute of Oncology
Budapest, Hungary
- Ospedali Riuniti Di Bergamo
Bergamo, Italy
- Ospedale Degli Infermi - Asl 12
Biella, Italy
- Ospedale Civile Ramazzini
Carpi, Italy
- Ospedale Alessandro Manzoni
Lecco, Italy
- European Institute of Oncology
Milan, Italy
- Auckland City Hospital
Auckland, New Zealand
- Oncology Institute of Southern Switzerland
Bellinzona, Switzerland
- Inselspital Bern
Bern, Switzerland
- Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
- Oncology Institute of Southern Switzerland - Locarno
Locarno, Switzerland
- Oncology Institute of Southern Switzerland - Lugano
Lugano, Switzerland
- Oncology Institute of Southern Switzerland - Mendrisio
Mendrisio, Switzerland
- Regionalspital
Thun, Switzerland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2003
- Primary completion
- 31 Jan 2014
- Completion
- 30 Sept 2016
- Last update posted
- 30 Dec 2019
- Registered enrollment
- 257
- Registry id
- NCT00068601
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.